Skip to main content
Have a personal or library account? Click to login
Molecular Characterization of ESBL-producing uropathogenic Escherichia coli From Pregnant Women: Resistance Genes, Integrons, and Virulence Profiles Cover

Molecular Characterization of ESBL-producing uropathogenic Escherichia coli From Pregnant Women: Resistance Genes, Integrons, and Virulence Profiles

Open Access
|Sep 2026
Read online

Figures & tables

graphic/pjm-2026-030-graphabs.jpg
Fig. 1.

Study flow diagram showing enrollment, exclusions, and classification of 280 E. coli isolates from pregnant women with urinary tract infections. ASB, asymptomatic bacteriuria.

Table I

Primer sequences for antimicrobial resistance genes and integron gene cassettes.

PrimerSequence (5’-3’)Amplicon (bp)TmRef
blaTEM-FAGTATTCAACATTTYCGTGT84756°CCopur Cicek et al. 2013
blaTEM-RTAATCAGTGAGGCACCTATCTC
blaSHV-FATGCGTTATATTCGCCTGTG84355°CCopur Cicek et al. 2013
blaSHV-RTTAGCGTTGCCAGTGCTC
blaCTX-M1-FGCGTGATACCACTTCACCTC26055°CCopur Cicek et al. 2013
blaCTX-M1-RTGAAGTAAGTGACCAGAATC
blaCTX-M2-FTGATACCACCACGCCGCTC34155°CCopur Cicek et al. 2013
blaCTX-M2-RTATTGCATCAGAAACCGTGGG
blaIMP-FCATGGTTTGGTGGTTCTTGT48856°CCopur Cicek et al. 2016
blaIMP-RATAATTTGGCGGACTTTGGC
blaNDM-FGAGATTGCCGAGCGACTTG49757°CCopur Cicek et al. 2016
blaNDM-RCGAATGTCTGGCAGCACACTT
blaVEB-FATTTCCCGATGCAAAGCGT54255°CCopur Cicek et al. 2016
blaVEB-RTTATTCCGGAAGTCCCTGT
blaVIM-FATTGGTCTATTTGACCGCGTC78058°CCopur Cicek et al. 2016
blaVIM-RTGCTACTCAACGACTGAGCG
blaPER-2-FATGAATGTCATCACAAAATG86045°CCopur Cicek et al. 2016
blaPER-2-RATAATAGCTTCATTGGTTC
blaGES-FATGCGCTTCATTCACGCAC86356°CCopur Cicek et al. 2016
blaGES-RCTATTTGTCCGTGCTCAGGA
blaKPC-FATGTCACTGTATCGCCGTCT89355°CCopur Cicek et al. 2016
blaKPC-RTTTTCAGAGCCTTACTGCCC
intI-FGGTCAAGGATCTGGATTTGG50057°CMachado et al. 2005
intI-RACATGCGTGTAAATCATCGTC
intII-FCACGGATATGCGACAAAAAGGT74057°CMachado et al. 2005
intII-RGTAGCAAACGAGTGACGAAATG
5’-CSGGCATCCAAGCAGCAAGVariable55°CMachado et al. 2005
3’-CSAAGCAGACTTGACCTGA
Table II

Primer sequences for uropathogenic virulence genes.

GenePrimer Sequence (5’-3’)Amplicon (bp)TmRef
papF: GCAACAGCAACGCTGGTTGCATCAT33663°C(Arisoy et al. 2006)
R: AGAGAGAGCCACTCTTATACGGACA
sfaF: CTCCGGAGAACTGGGTGCATCTTAC41063°C(Arisoy et al. 2006)
R: CGGAGGAGTAATTACAAACCTGGCA
cnfF: AAGATGGAGTTTCCTATGCAGGAG49863°C(Arisoy et al. 2006)
R: CATTCAGAGTCCTGCCCTCATTATT
aerF: TACCGGATTGTCATATGCAGACCGT60263°C(Arisoy et al. 2006)
R: AATATCTTCCTCCAGTCCGGAGAAG
afaF: CGGCTTTTCTGCTGAACTGGCAGGC67263°C(Arisoy et al. 2006)
R: CCGTCAGCCCCCACGGCAGACC
hlyF: AACAAGGATAAGCACTGTTCTGGCT117763°C(Arisoy et al. 2006)
R: ACCATATAAGCGGTCATTCCCGTCA
Table III

Antimicrobial resistance profiles: overall and stratified by ESBL status.

AntibioticAll (n=280) %ESBL+ (n=53) %ESBL− (n=227) %p-value
Ampicillin75.310069.6<0.001
Amoxicillin-clavulanic acid43.950.942.30.323
Cefuroxime24.61007.0<0.001
Cefotaxime20.71002.2<0.001
Ceftazidime19.21000.4<0.001
Ceftriaxone18.296.20.0<0.001
Cefepime16.084.90.0<0.001
Piperacillin-tazobactam9.347.20.4<0.001
TMP-SMX26.467.916.7<0.001
Ciprofloxacin34.252.830.00.003
Nitrofurantoin3.217.00.0<0.001
Fosfomycin2.19.40.40.001
Gentamicin1.85.70.90.048
Amikacin1.13.80.40.093
Imipenem000--
Meropenem000--

[i] color coding: red >50%, orange 20-49%, yellow 5-19%, green <5%

[ii] Chi-square or Fisher’s exact test as appropriate; R – resistant; S – susceptible; NS – not significant

Table IV

Distribution of resistance genes and integron elements (n = 53).

Gene / Elementn / 53%
blaCTX-M12954.7
blaCTX-M21528.3
blaTEM815.0
blaSHV59.4
intI (Class 1)2037.7
intII (Class 2)11.9
5’-CS / 3’-CS1018.9
hep51/hep7400
Table V

Virulence genes stratified by clinical presentation (n = 52 classified + 1 unclassified).

GeneTotal (n=53)%Cystitis (n=27)Pyelonephritis (n=7)ASB (n=18)Unclassified (n=1)
aer2037.713 (48.1)4 (57.1)3 (16.7)0
sfa1222.67 (25.9)4 (57.1)1 (5.6)0
afa916.96 (22.2)3 (42.8)00
pap916.97 (25.9)2 (28.5)00
cnf11.9001 (5.6)0
hly000000
Table VI

Virulence gene combinations among ESBL-positive isolates (n = 53).

Gene combinationn%
sfa + aer59.4
sfa + pap59.4
sfa + pap + aer11.9
sfa + aer + cnf11.9
afa only917.0
No virulence gene1732.1
Fig. 2.

Virulence gene prevalence by clinical category. Note the consistently higher detection rates in pyelonephritis (n = 7) compared with cystitis (n = 27) and ASB (n = 18). hly was not detected and is omitted.

Fig. 3.

Heatmap showing co-occurrence of resistance genes, integron elements, and virulence factors among 53 ESBL-positive isolates. Values represent the percentage of isolates carrying both determinants simultaneously.

Fig. 4.

Comparison of resistance gene prevalence, virulence gene carriage, and MDR status between integron-positive (intI+, n = 20) and integron-negative (intI-, n = 33) ESBL-producing E. coli isolates. Integron-carrying isolates showed consistently higher gene loads across all categories.

DOI: https://doi.org/10.33073/pjm-2026-030 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 370 - 383
Submitted on: Jul 21, 2026
Accepted on: Sep 3, 2026
Published on: Sep 30, 2026
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Yasemin AY Altintop, Nebahat Aydogan Ejder, Huseyin Aksoy, Aysegul Copur Cicek, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.